In BriefSCI COMMUN

News at a glance

See allHide authors and affiliations

Science  16 Jul 2021:
Vol. 373, Issue 6552, pp. 260-261
DOI: 10.1126/science.373.6552.260

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

In science news around the world, the United Kingdom forges ahead with plans to lift virtually all coronavirus restrictions, despite a plea from health researchers to hit the pause button. Facing criticism for its recent approval of an Alzheimer's disease treatment, the U.S. Food and Drug Administration (FDA) narrows the group of patients for whom it recommends Biogen's drug aducanumab, marketed as Aduhelm. Pfizer and BioNTech draw rare public pushback from top U.S. health agencies after the companies announce they will soon seek regulatory authorization for a booster dose of their vaccine against SARS-CoV-2. FDA updates the fact sheet on Johnson & Johnson's COVID-19 vaccine to suggest an increased risk of Guillain-Barré syndrome, a rare neurological malady. Iran decides to manufacture enriched uranium fuel for a research reactor in Tehran that produces medical isotopes, further clouding the fate of the Iran nuclear deal. Subcommittees in the U.S. House of Representatives approve significant budget increases for key science agencies in 2022.

View Full Text

Stay Connected to Science